コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ngly, more active transforming growth factor beta.
2 hat mediate stellate cell activation via TGF-beta.
3 structures increase in cells exposed to IFN-beta.
6 ted through later poverty at age 7-14 years (beta = -0.01, 95% confidence interval: -0.04, 0.01) and
7 ater LTL attrition (3 herpesviruses vs none, beta = -0.07 and P = .02; 4 infections vs none, beta = -
8 ion at age 7-14 years (i.e., joint mediators beta = -0.07, 95% confidence interval: -0.12, -0.02) tha
9 medial (beta = -0.22, P = .03) and lateral (beta = -0.08, P = .03) temporal regions, subcortical whi
10 temporal regions, subcortical white matter (beta = -0.13, P = .02), and occipital regions (beta = -0
12 ta = -0.13, P = .02), and occipital regions (beta = -0.15, P = .03) in the whole sample and the occip
14 the whole sample and the occipital regions (beta = -0.21, P = .01) in the CN subsample statistically
15 ver, APOE epsilon4 rendered only the medial (beta = -0.22, P = .03) and lateral (beta = -0.08, P = .0
17 th Panic and Agoraphobia scale (PAS) scores (beta=0.005, SE=0.002, p=0.021, n=131) among cases in the
18 etween exposure to p,p'-DDE and BMI z-score (beta=0.13 BMI z-score (95% CI: 0.01, 0.25) per log incre
20 in blood was negatively associated with age (beta=-0.03/10 y; r(2)=0.07; P=1.6x10(-7)) but not with c
21 n those without (29.6pg/ml, IQR = 20.9-41.8; beta = 1.461, p = 0.005 and beta = 1.902, p = 0.002, res
23 ore was associated with both binocular 24-2 (beta = 1.95; 95% CI, 0.47-3.43; P = .01) and 10-2 (beta
25 of defence related enzymes, i.e. chitinase, beta-1,3-glucanase and PAL, and higher content of epicat
26 monstration that an SRRP is required to bind beta-1,4-linked galactose and the first time that one of
27 and positron emission tomography for amyloid-beta ((11) C-PiB or (18) F-florbetapir) and tau ((18) F-
28 ociated with lower QRS Sokolow-Lyon voltage (beta = 15.1 microV/10 msec, P = .004), lower QRS Cornell
29 mg every 24 weeks or subcutaneous interferon beta-1a at a dose of 44 mug three times weekly for 96 we
32 1.95; 95% CI, 0.47-3.43; P = .01) and 10-2 (beta = 2.57; 95% CI, 1.12-4.01; P = .001) sensitivities,
33 ation of 18 compounds (mixture of anabolics, beta-2 agonists, diuretics, stimulants, narcotics, and b
34 msec, P = .004), lower QRS Cornell voltage (beta = 9.2 microV/10 msec, P = .031), and shorter QRS du
35 idogenic cleavage of APP and produce amyloid beta (Abeta) at the expense of sAPPalpha and other non-a
37 of Alzheimer's disease (AD) include amyloid-beta (Abeta) plaques, neurofibrillary tangles, and react
38 eurologically normal elderly without amyloid-beta accumulation (normal ageing, n = 13), and neurologi
40 ormone (TH) and TH receptors (TRs) alpha and beta act by binding to TH response elements (TREs) in re
42 showed that the fast reaction corresponds to beta-adduct formation (the kinetic product), while the s
44 tially reflecting down-regulation of cardiac beta-adrenergic receptor function in chronic hypoxia.
46 r environments could control beta-synuclein (betaS) aggregation via altering its charge distribution,
47 ded for five different photoredox reactions (beta-alkylation, beta-aminoalkylation, dehalogenation, a
49 erent photoredox reactions (beta-alkylation, beta-aminoalkylation, dehalogenation, amine arylation, a
53 AMPK activity also failed to up-regulate IFN-beta and TNF-alpha after treatment with DMXAA or the nat
54 ted, demonstrating both collision frequency (beta) and background particle concentration (B) to be in
57 was markedly disordered, suggesting that the beta-annulus had been disrupted and that this could dest
60 rminal peptide competed for association with beta-arrestin 1, and phosphorylated central or distal C-
61 Both in G protein-mediated pathways and in beta-arrestin 2 recruitment, no ligand-independent activ
63 Results from controlled expression of either beta-arrestin isoform demonstrate that beta-arrestin2 ac
66 beta-arrestin2 acts in an opposite manner to beta-arrestin1 by promoting degradation of an unstimulat
68 ither beta-arrestin isoform demonstrate that beta-arrestin2 acts in an opposite manner to beta-arrest
72 ctive hypothesis, which posits that top-down beta-band influences directly modulate bottom-up gamma b
73 ces of a salient target were associated with beta-band suppression, and target reappearances with bet
75 in complex responsible for the biogenesis of beta-barrel outer membrane proteins (OMPs) in Gram-negat
78 tin prescriptions included male sex, filling beta-blocker and antiplatelet agent prescriptions, and a
80 nists, diuretics, stimulants, narcotics, and beta-blockers) spiked in human urine and plasma samples.
81 statins, renin-angiotensin system blockers, beta-blockers, dual antiplatelet therapy, and long-term
82 0%, type of surgery, and preoperative use of beta-blockers, intra-aortic balloon pump, or catecholami
89 cessibility of phenolics, flavonoids, rutin, beta-carotene and lutein and changes in antioxidant acti
92 ctions between ORF2 and a complex containing beta-catenin and HMGA1 have functional significance.
93 ssion levels were negatively correlated with beta-catenin and PKM2 levels in breast cancer tissues.
94 observations are consistent with the role of beta-catenin and SNAIL in epidermal stem cell maintenanc
97 , followed by phosphorylation of and loss of beta-catenin from the nucleus, thereby reducing expressi
98 triggers the mechanosensitive activation of beta-catenin in adjacent epidermal cells, initiating the
99 atenin levels and define PKC as an important beta-catenin interaction partner and signaling opponent
100 identified a novel pathway for regulation of beta-catenin levels and define PKC as an important beta-
102 S2 overexpression in ACC cells inhibited Wnt/beta-catenin pathway activity by promoting beta-catenin
105 t/beta-catenin pathway activity by promoting beta-catenin phosphorylation and degradation, it also in
107 y, we investigated the molecular role of Wnt/beta-catenin signaling pathway in reparative dentinogene
108 dentified LGR4 as a master controller of Wnt/beta-catenin signaling-mediated breast cancer tumorigene
112 -beta-catenin tumors showed up-regulation of beta-catenin targets like glutamine synthetase (GS), leu
114 of the culture system, IWP2 decreased total beta-catenin while CHIR99021 increased it in nuclear loc
115 imultaneously coordinates the attenuation of beta-catenin, both of which are required to execute the
116 es downstream of LRP6, including JNK and WNT/beta-catenin, inhibited the biologic activity of domain
118 in estrogen receptor, progesterone receptor, beta-catenin, or vimentin expression between placebo and
120 egulation may promote beta-oxidation through beta-catenin, whereas hypertrophy was dependent on mamma
121 y enhanced the ability of HMGA1 to stimulate beta-catenin-dependent transcription, suggesting that in
122 po1), an extracellular protein that enhances beta-catenin-dependent Wnt signaling and has previously
123 ppress GC growth through a novel SOCE/Ca(2+)/beta-catenin-mediated anti-proliferation of GC cells, wh
129 ining of the expression of genes involved in beta cell function, but also continual repression of clo
130 ll, indicating that acquiring and sustaining beta cell identity and function requires not only active
133 monstrates the highly volatile nature of the beta cell, indicating that acquiring and sustaining beta
141 al role of inflammation in cytokine-mediated beta-cell dysfunction and death in type 1 diabetes melli
142 oreover, chronically elevated glucose causes beta-cell dysfunction, but little is known about how cel
143 n mediating the effect of leptin to modulate beta-cell electrical activity by promoting AMP-activated
144 While mitophagy is critical to pancreatic beta-cell function, the posttranslational signals govern
150 strongly suggest that an early deficiency in beta-cell number in infants with CF may contribute to th
151 ession has recently been described as highly beta-cell selective in the human pancreas and constitute
152 es of hypoglycaemia and can be due either to beta-cell tumours (insulinomas) or beta-cell hyperplasia
153 served sequences that control pancreatic and beta-cell type-specific transcription, which are found w
156 1 is cytoprotective to rat, mouse, and human beta-cells exposed to cytokines or thapsigargin-induced
157 Inhibition of KCC2 activity in clonal MIN6 beta-cells increases basal and glucose-stimulated insuli
159 apoptotic Bcl-2 proteins in human pancreatic beta-cells, broadening our understanding of cytokine-ind
163 e experiments showed that alpha-cellular and beta-cellular clocks are oscillating with distinct phase
164 s regulating BACE1 distribution in axons and beta cleavage of APP at synapses remain largely unknown.
165 iated APP mutation, shifted the preferential beta-cleavage site of BACE1 in APP from the Glu(11) site
166 ive interface exchange between the TCR alpha/beta constant domain pair and the IgG1 CH3 homodimer was
167 Together these data demonstrate that pol beta contains a specific NLS sequence in the N-terminal
169 d-glucosaminyl)-1,2,3-triazoles as well as C-beta-d-glucosaminyl 1,2,4-triazoles and imidazoles were
173 ow that the same as for genes SPAD follows a beta distribution, which provides a good description of
174 ughout the signaling duration and across Tgf-beta doses, and significantly increased the information
176 route in six steps; however, both alpha and beta epimers could be obtained by a nonstereoselective a
177 neous type 2 airway inflammation in juvenile beta-epithelial Na(+) channel (Scnn1b)-transgenic (Tg) m
179 docyte injury, fibronectin accumulation, TGF-beta expression, and, most notably, age-related impairme
181 r the synthesis of chiral beta-hydroxylated, beta-fluorinated, and beta-arylated carboxylic acids.
184 on-invasive imaging of Hmox1 expression, and beta-galactosidase for high-resolution mapping of expres
185 on MnO2 with different morphologies (alpha, beta, gamma and delta) was investigated using flow tube
186 cyclic sulfamidate imines with a variety of beta,gamma-unsaturated alpha-ketocarbonyls in neat condi
188 s could be obtained by removal of a terminal beta-GlcNAc moiety by treatment with beta-N-acetylglucos
190 tilization of yeast and fungal cell wall 1,6-beta-glucans is a widespread adaptation within the human
198 ties of At2g44920 as a representative of the beta-helix family to determine if it had exceptional glo
199 was observed when the sequence begins with a beta-hGly residue instead of a (S)-beta-Caa(l) constitue
204 useful synthons for the synthesis of chiral beta-hydroxylated, beta-fluorinated, and beta-arylated c
205 ai virus infection efficiency, decreased IFN-beta, IFN-lambda1, and interferon-stimulated chemokine g
206 utation in the actin-binding domain (ABD) of beta-III-spectrin causes high-affinity actin binding and
208 ndidate therapeutic targets to lower amyloid-beta in a preventive mode, i.e., gamma- and beta-secreta
209 ibution, thus opening new possible roles for betaS in Parkinson's and other neurodegenerative disease
211 OPTN and NDP52), thereby alleviating amyloid-beta-induced loss of synapses and cognitive decline in A
212 associated decrease in tumor necrosis factor-beta, interferon-gamma, and monocyte chemoattractant pro
215 chiral N-tert-butanesulfinyl aldimines with beta-keto acids under basic conditions at room temperatu
216 lf) and a dihydrodipyrrin substituted with a beta-ketoester (BC half) forms a propenone bearing the t
219 uberculosis (Mtb) expresses a broad-spectrum beta-lactamase (BlaC) that mediates resistance to one of
220 e boronic acid synergy test, and the metallo-beta-lactamase Etest, had specificities of >90% for dete
223 oxamates facilitated syntheses of monocyclic beta-lactams suitable for incorporation of a thiomethyl
226 ioselective synthesis of N-heterocycle-fused-beta-lactones from N-linked ketoacids is described.
227 markers useful for in vivo dose responses of beta-lapachone treatment in humans, avoiding toxic side
229 pecies and other proteins related to amyloid-beta metabolism or Alzheimer's disease were quantified b
231 take was highest on delta-MnO2 but lowest on beta-MnO2, with a geometric uptake coefficient (gammaobs
233 ned the same overall structure of native TGF-beta monomers and bound TbetaRII in an identical manner.
235 icity to OGA in O-GlcNAc regulation.O-linked beta-N-acetyl glucosamine (O-GlcNAc) is an important pro
236 ification of nucleocytoplasmic proteins with beta-N-acetylglucosamine (GlcNAc) and regulates numerous
237 erminal beta-GlcNAc moiety by treatment with beta-N-acetylglucosaminidase and selective extension of
240 with only beta-O-4 linkages, or both 5-5 and beta-O-4 linkages, showed major 1,2-eliminations of neut
242 Smad transcription factors activated by TGF-beta or by BMP receptors form trimeric complexes with Sm
243 gonist-induced activation of phospholipase C beta or with a rapamycin-inducible system in which vario
245 t farther from a movement onset state during beta oscillations that were neurofeedback-induced or nat
248 purine and pyrimidine metabolism, fatty acid beta-oxidation, phospholipid catabolism, arachidonic aci
250 rocyclization of alpha-(N-hydroxy/aryl)imino-beta-oxodithioesters with in situ generated Cu-carbenoid
251 of some species with prunasin, tyramine and beta-p-arbutin, may be limited in food applications.
257 the relative contribution of endogenous TGF-beta proteins to the negative regulation of muscle mass
261 in levels of fibrosis signaling mediator TGF-beta remained the same and the second messenger, Smad2/3
263 -beta in a preventive mode, i.e., gamma- and beta-secretase; the rationale behind these two targets;
267 l acidic region of Ng peptide pries open the beta-sheet structure between the Ca(2+) binding loops pa
268 cm(-1)), H-bonded parallel- and antiparallel-beta-sheets (1690cm(-1)) and H-bonded beta-turns (1664cm
271 s and attenuated the upregulation of the TGF-beta signaling pathway and alpha1-antitrypsin protein (a
272 t a pharmacological compound that abates TGF-beta signalling and enhances ERK5 signalling may be usef
273 te tensile strength (UTS) for two engineered beta-solenoid protein mutant fibril structures (spruce b
276 31 of Escherichia coli RNA polymerase (RNAP) beta subunit is a part of RNA binding domain in transcri
277 s the protein into a large membrane-anchored beta subunit that noncovalently associates with the smal
282 ifferent cellular environments could control beta-synuclein (betaS) aggregation via altering its char
284 ic growth factor, transforming growth factor beta (TGF-beta), is thought to play a pivotal role.
285 was activated by transforming growth factor beta (TGFbeta)-activated kinase 1 (TAK1; MAP3K7), which
289 owing: i) increased Gsk3beta activation, ii) beta-transducin repeat containing E3 ubiquitin protein l
291 relevance of thymic function, measured by sj/beta-TREC ratio, in HIV disease progression by analyzing
292 omain-containing adapter-inducing interferon-beta (TRIF) and Z-DNA-binding protein 1 (ZBP1)/DNA-depen
293 ther the mutation resided within the Tubb4a (beta-tubulin 4A) gene, because mutations in the TUBB4A g
298 ion of this approach also afforded (Z)-alpha,beta-unsaturated amino esters in moderate to good yields
299 for the construction of (hetero)cyclic alpha,beta-unsaturated carboxylic acids from 1,6- and 1,7-enye
300 induces pro-angiogenic responses through TGF-beta, which may act as the bridging molecule that mediat
301 rban form on NO2 is larger for small cities (beta x IQR = -0.46 for cities < approximately 300000 peo
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。